British Scientist to Receive $3.5 Million U.S. Grant for Botulism Vaccine
The U.S. National Institute of Allergy and Infectious Diseases is today expected to announce a $3.5 million federal grant to fund research on the first stable vaccine against airborne botulism poisoning, the London Daily Telegraph reported (see GSN, Jan. 12, 2004).
Stockpiles of the liquid vaccine could be produced by 2008 under the auspices of Project Bioshield, according to Bruce Roser, chief scientist at Cambridge Biostability in the United Kingdom (Nic Fleming, Daily Telegraph, Feb. 28).
Stockpiles of the liquid vaccine could be produced by 2008 under the auspices of Project Bioshield, according to Bruce Roser, chief scientist at Cambridge Biostability in the United Kingdom (Nic Fleming, Daily Telegraph, Feb. 28).
